| Type |
Details |
Score |
| Gene |
| Type: |
gene |
| Organism: |
human |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, western clawed |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
hamster, Chinese |
|
•
•
•
•
•
|
| Gene |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
dog, domestic |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
chimpanzee |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
cattle |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
chicken |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
zebrafish |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Toll-like receptor 2 (TLR2) is a member of the Toll-like receptor (TLR) family, which plays a role in activation of innate immunity and pathogen recognition []. It helps mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components, acting via MyD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response [, , , ]. TLR2 in association with TLR1 or TLR6 is essential for recognising bacterial lipoproteins and lipopeptides [, ]. It also promotes apoptosis in response to lipoproteins [].Genetic variations in TLR2 are associated with susceptibility to leprosy, a chronic disease associated with depressed cellular (but not humoral) immunity [, ]. |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Takeuchi O |
| Year: |
2001 |
| Journal: |
Int Immunol |
| Title: |
Discrimination of bacterial lipoproteins by Toll-like receptor 6. |
| Volume: |
13 |
| Issue: |
7 |
| Pages: |
933-40 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Takeuchi O |
| Year: |
2002 |
| Journal: |
J Immunol |
| Title: |
Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. |
| Volume: |
169 |
| Issue: |
1 |
| Pages: |
10-4 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sheedy FJ |
| Year: |
2007 |
| Journal: |
J Leukoc Biol |
| Title: |
The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling. |
| Volume: |
82 |
| Issue: |
2 |
| Pages: |
196-203 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Droemann D |
| Year: |
2003 |
| Journal: |
Histochem Cell Biol |
| Title: |
Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. |
| Volume: |
119 |
| Issue: |
2 |
| Pages: |
103-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bochud PY |
| Year: |
2008 |
| Journal: |
J Infect Dis |
| Title: |
Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. |
| Volume: |
197 |
| Issue: |
2 |
| Pages: |
253-61 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Aliprantis AO |
| Year: |
1999 |
| Journal: |
Science |
| Title: |
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. |
| Volume: |
285 |
| Issue: |
5428 |
| Pages: |
736-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bochud PY |
| Year: |
2003 |
| Journal: |
J Immunol |
| Title: |
Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. |
| Volume: |
170 |
| Issue: |
7 |
| Pages: |
3451-4 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schröder NW |
| Year: |
2003 |
| Journal: |
J Biol Chem |
| Title: |
Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. |
| Volume: |
278 |
| Issue: |
18 |
| Pages: |
15587-94 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kirschning CJ |
| Year: |
2001 |
| Journal: |
Int J Med Microbiol |
| Title: |
Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses. |
| Volume: |
291 |
| Issue: |
4 |
| Pages: |
251-60 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Brightbill HD |
| Year: |
1999 |
| Journal: |
Science |
| Title: |
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. |
| Volume: |
285 |
| Issue: |
5428 |
| Pages: |
732-6 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
784
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
784
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
784
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
784
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hoffmann O |
| Year: |
2007 |
| Journal: |
J Immunol |
| Title: |
TLR2 mediates neuroinflammation and neuronal damage. |
| Volume: |
178 |
| Issue: |
10 |
| Pages: |
6476-81 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim DH |
| Year: |
2011 |
| Journal: |
J Immunol |
| Title: |
Inhibition of autoimmune diabetes by TLR2 tolerance. |
| Volume: |
187 |
| Issue: |
10 |
| Pages: |
5211-20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Reyes JL |
| Year: |
2011 |
| Journal: |
Int J Biol Sci |
| Title: |
TLR2 mediates immunity to experimental cysticercosis. |
| Volume: |
7 |
| Issue: |
9 |
| Pages: |
1323-33 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Do KN |
| Year: |
2012 |
| Journal: |
PLoS One |
| Title: |
TLR2 controls intestinal carcinogen detoxication by CYP1A1. |
| Volume: |
7 |
| Issue: |
3 |
| Pages: |
e32309 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Imanishi T |
| Year: |
2007 |
| Journal: |
J Immunol |
| Title: |
Cutting edge: TLR2 directly triggers Th1 effector functions. |
| Volume: |
178 |
| Issue: |
11 |
| Pages: |
6715-9 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:6185206 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2018-07-25 |
| Strength: |
Absent |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689419 |
|
| Stage: |
TS19 |
| Assay Id: |
MGI:6191486 |
| Age: |
embryonic day 11.5 |
|
|
| Specimen Label: |
Table S2 - E11.5 - Tlr2 |
| Detected: |
false |
| Specimen Num: |
1 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:6185206 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2018-07-25 |
| Strength: |
Absent |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689421 |
|
| Stage: |
TS21 |
| Assay Id: |
MGI:6191486 |
| Age: |
embryonic day 13.5 |
|
|
| Specimen Label: |
Table S2 - E13.5 - Tlr2 |
| Detected: |
false |
| Specimen Num: |
2 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:6185206 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2018-07-25 |
| Strength: |
Absent |
| Sex: |
Male |
| Emaps: |
EMAPS:1689424 |
|
| Stage: |
TS24 |
| Assay Id: |
MGI:6191486 |
| Age: |
embryonic day 15.5 |
|
|
| Specimen Label: |
Table S2 - E15.5 - Tlr2 |
| Detected: |
false |
| Specimen Num: |
3 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:6185206 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2018-07-25 |
| Strength: |
Absent |
| Sex: |
Male |
| Emaps: |
EMAPS:1689426 |
|
| Stage: |
TS26 |
| Assay Id: |
MGI:6191486 |
| Age: |
embryonic day 18.5 |
|
|
| Specimen Label: |
Table S2 - E18.5 - Tlr2 |
| Detected: |
false |
| Specimen Num: |
4 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:6185206 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2018-07-25 |
| Strength: |
Absent |
| Sex: |
Male |
| Emaps: |
EMAPS:1689428 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:6191486 |
| Age: |
postnatal day 4 |
|
|
| Specimen Label: |
Table S2 - P4 - Tlr2 |
| Detected: |
false |
| Specimen Num: |
5 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:6185206 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2018-07-25 |
| Strength: |
Absent |
| Sex: |
Male |
| Emaps: |
EMAPS:1689428 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:6191486 |
| Age: |
postnatal day 14 |
|
|
| Specimen Label: |
Table S2 - P14 - Tlr2 |
| Detected: |
false |
| Specimen Num: |
6 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:6185206 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2018-07-25 |
| Strength: |
Absent |
| Sex: |
Male |
| Emaps: |
EMAPS:1689428 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:6191486 |
| Age: |
postnatal day 28 |
|
|
| Specimen Label: |
Table S2 - P28 - Tlr2 |
| Detected: |
false |
| Specimen Num: |
7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Beaulieu LM |
| Year: |
2011 |
| Journal: |
Blood |
| Title: |
Regulatory effects of TLR2 on megakaryocytic cell function. |
| Volume: |
117 |
| Issue: |
22 |
| Pages: |
5963-74 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sugawara I |
| Year: |
2003 |
| Journal: |
Microbiol Immunol |
| Title: |
Mycobacterial infection in TLR2 and TLR6 knockout mice. |
| Volume: |
47 |
| Issue: |
5 |
| Pages: |
327-36 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shmuel-Galia L |
| Year: |
2016 |
| Journal: |
EMBO J |
| Title: |
Neutralization of pro-inflammatory monocytes by targeting TLR2 dimerization ameliorates colitis. |
| Volume: |
35 |
| Issue: |
6 |
| Pages: |
685-98 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pecora ND |
| Year: |
2006 |
| Journal: |
J Immunol |
| Title: |
Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. |
| Volume: |
177 |
| Issue: |
1 |
| Pages: |
422-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yadav M |
| Year: |
2006 |
| Journal: |
Blood |
| Title: |
The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. |
| Volume: |
108 |
| Issue: |
9 |
| Pages: |
3168-75 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chu HW |
| Year: |
2005 |
| Journal: |
J Immunol |
| Title: |
TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. |
| Volume: |
174 |
| Issue: |
9 |
| Pages: |
5713-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Leemans JC |
| Year: |
2005 |
| Journal: |
J Clin Invest |
| Title: |
Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. |
| Volume: |
115 |
| Issue: |
10 |
| Pages: |
2894-903 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Maruyama A |
| Year: |
2015 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling. |
| Volume: |
457 |
| Issue: |
3 |
| Pages: |
445-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mariano VS |
| Year: |
2014 |
| Journal: |
PLoS One |
| Title: |
Recognition of TLR2 N-glycans: critical role in ArtinM immunomodulatory activity. |
| Volume: |
9 |
| Issue: |
6 |
| Pages: |
e98512 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pope MR |
| Year: |
2015 |
| Journal: |
J Immunol |
| Title: |
TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation. |
| Volume: |
194 |
| Issue: |
3 |
| Pages: |
1190-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Okun E |
| Year: |
2010 |
| Journal: |
J Neurochem |
| Title: |
TLR2 activation inhibits embryonic neural progenitor cell proliferation. |
| Volume: |
114 |
| Issue: |
2 |
| Pages: |
462-74 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bai Y |
| Year: |
2014 |
| Journal: |
Neurosci Lett |
| Title: |
TLR2 signaling directs NO-dependent MMP-9 induction in mouse microglia. |
| Volume: |
571 |
|
| Pages: |
5-10 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Park DW |
| Year: |
2013 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
TLR2 stimulates ABCA1 expression via PKC-η and PLD2 pathway. |
| Volume: |
430 |
| Issue: |
3 |
| Pages: |
933-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sun X |
| Year: |
2013 |
| Journal: |
PLoS One |
| Title: |
TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. |
| Volume: |
8 |
| Issue: |
9 |
| Pages: |
e74595 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Matsumoto Y |
| Year: |
2022 |
| Journal: |
J Clin Invest |
| Title: |
Tankyrase represses autoinflammation through the attenuation of TLR2 signaling. |
| Volume: |
132 |
| Issue: |
7 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cole LE |
| Year: |
2010 |
| Journal: |
J Leukoc Biol |
| Title: |
Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling. |
| Volume: |
87 |
| Issue: |
2 |
| Pages: |
275-81 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Huang QQ |
| Year: |
2013 |
| Journal: |
J Leukoc Biol |
| Title: |
TLR2 deletion promotes arthritis through reduction of IL-10. |
| Volume: |
93 |
| Issue: |
5 |
| Pages: |
751-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li S |
| Year: |
2015 |
| Journal: |
Cancer Res |
| Title: |
TLR2 limits development of hepatocellular carcinoma by reducing IL18-mediated immunosuppression. |
| Volume: |
75 |
| Issue: |
6 |
| Pages: |
986-95 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zheng M |
| Year: |
2021 |
| Journal: |
Nat Immunol |
| Title: |
TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. |
| Volume: |
22 |
| Issue: |
7 |
| Pages: |
829-838 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Papadopoulos G |
| Year: |
2013 |
| Journal: |
J Immunol |
| Title: |
Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss. |
| Volume: |
190 |
| Issue: |
3 |
| Pages: |
1148-57 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Teixeira-Coelho M |
| Year: |
2014 |
| Journal: |
Eur J Immunol |
| Title: |
Differential post-transcriptional regulation of IL-10 by TLR2 and TLR4-activated macrophages. |
| Volume: |
44 |
| Issue: |
3 |
| Pages: |
856-66 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim S |
| Year: |
2009 |
| Journal: |
Nature |
| Title: |
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. |
| Volume: |
457 |
| Issue: |
7225 |
| Pages: |
102-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wyczanska M |
| Year: |
2023 |
| Journal: |
PLoS One |
| Title: |
TLR2 mediates renal apoptosis in neonatal mice subjected experimentally to obstructive nephropathy. |
| Volume: |
18 |
| Issue: |
11 |
| Pages: |
e0294142 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lugade AA |
| Year: |
2011 |
| Journal: |
PLoS One |
| Title: |
Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling. |
| Volume: |
6 |
| Issue: |
5 |
| Pages: |
e19781 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ha T |
| Year: |
2010 |
| Journal: |
Cardiovasc Res |
| Title: |
TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. |
| Volume: |
87 |
| Issue: |
4 |
| Pages: |
694-703 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Henn A |
| Year: |
2011 |
| Journal: |
J Immunol |
| Title: |
TLR2 hypersensitivity of astrocytes as functional consequence of previous inflammatory episodes. |
| Volume: |
186 |
| Issue: |
5 |
| Pages: |
3237-47 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang TT |
| Year: |
2020 |
| Journal: |
Neuroscience |
| Title: |
Activation of Different Heterodimers of TLR2 Distinctly Mediates Pain and Itch. |
| Volume: |
429 |
|
| Pages: |
245-255 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Himes RW |
| Year: |
2010 |
| Journal: |
FASEB J |
| Title: |
Tlr2 is critical for diet-induced metabolic syndrome in a murine model. |
| Volume: |
24 |
| Issue: |
3 |
| Pages: |
731-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Brown HJ |
| Year: |
2006 |
| Journal: |
J Immunol |
| Title: |
TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. |
| Volume: |
177 |
| Issue: |
3 |
| Pages: |
1925-31 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dasu MR |
| Year: |
2010 |
| Journal: |
Lab Invest |
| Title: |
TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice. |
| Volume: |
90 |
| Issue: |
11 |
| Pages: |
1628-36 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lin H |
| Year: |
2013 |
| Journal: |
PLoS One |
| Title: |
Antioxidant N-acetylcysteine attenuates hepatocarcinogenesis by inhibiting ROS/ER stress in TLR2 deficient mouse. |
| Volume: |
8 |
| Issue: |
10 |
| Pages: |
e74130 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Huang Y |
| Year: |
2016 |
| Journal: |
Pediatr Res |
| Title: |
TLR2 promotes macrophage recruitment and Streptococcus pneumoniae clearance during mouse otitis media. |
| Volume: |
80 |
| Issue: |
6 |
| Pages: |
886-893 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Santos-Sierra S |
| Year: |
2009 |
| Journal: |
EMBO J |
| Title: |
Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. |
| Volume: |
28 |
| Issue: |
14 |
| Pages: |
2018-27 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mistry P |
| Year: |
2015 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain. |
| Volume: |
112 |
| Issue: |
17 |
| Pages: |
5455-60 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
McKelvey AC |
| Year: |
2016 |
| Journal: |
Elife |
| Title: |
RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity. |
| Volume: |
5 |
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Szomolanyi-Tsuda E |
| Year: |
2006 |
| Journal: |
J Virol |
| Title: |
Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. |
| Volume: |
80 |
| Issue: |
9 |
| Pages: |
4286-91 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rodriguez AR |
| Year: |
2012 |
| Journal: |
J Immunol |
| Title: |
Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis. |
| Volume: |
188 |
| Issue: |
11 |
| Pages: |
5604-11 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nichols JR |
| Year: |
2009 |
| Journal: |
J Immunol |
| Title: |
TLR2 deficiency leads to increased Th17 infiltrates in experimental brain abscesses. |
| Volume: |
182 |
| Issue: |
11 |
| Pages: |
7119-30 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sørensen LN |
| Year: |
2008 |
| Journal: |
J Immunol |
| Title: |
TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. |
| Volume: |
181 |
| Issue: |
12 |
| Pages: |
8604-12 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Myneni SR |
| Year: |
2011 |
| Journal: |
J Immunol |
| Title: |
TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. |
| Volume: |
187 |
| Issue: |
1 |
| Pages: |
501-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gao Y |
| Year: |
2013 |
| Journal: |
PLoS One |
| Title: |
TLR2 directing PD-L2 expression inhibit T cells response in Schistosoma japonicum infection. |
| Volume: |
8 |
| Issue: |
12 |
| Pages: |
e82480 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xu WY |
| Year: |
2007 |
| Journal: |
Mol Immunol |
| Title: |
TLR2 and TLR4 agonists synergistically up-regulate SR-A in RAW264.7 through p38. |
| Volume: |
44 |
| Issue: |
9 |
| Pages: |
2315-23 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
He X |
| Year: |
2011 |
| Journal: |
PLoS One |
| Title: |
Enhanced virulence of Chlamydia muridarum respiratory infections in the absence of TLR2 activation. |
| Volume: |
6 |
| Issue: |
6 |
| Pages: |
e20846 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ziegler G |
| Year: |
2007 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
TLR2 has a detrimental role in mouse transient focal cerebral ischemia. |
| Volume: |
359 |
| Issue: |
3 |
| Pages: |
574-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li F |
| Year: |
2018 |
| Journal: |
Tuberculosis (Edinb) |
| Title: |
LpqT improves mycobacteria survival in macrophages by inhibiting TLR2 mediated inflammatory cytokine expression and cell apoptosis. |
| Volume: |
111 |
|
| Pages: |
57-66 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tye H |
| Year: |
2012 |
| Journal: |
Cancer Cell |
| Title: |
STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. |
| Volume: |
22 |
| Issue: |
4 |
| Pages: |
466-78 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu G |
| Year: |
2011 |
| Journal: |
PLoS One |
| Title: |
The receptor for urokinase regulates TLR2 mediated inflammatory responses in neutrophils. |
| Volume: |
6 |
| Issue: |
10 |
| Pages: |
e25843 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jones CL |
| Year: |
2011 |
| Journal: |
PLoS One |
| Title: |
TLR2 signaling contributes to rapid inflammasome activation during F. novicida infection. |
| Volume: |
6 |
| Issue: |
6 |
| Pages: |
e20609 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gutjahr A |
| Year: |
2017 |
| Journal: |
J Immunol |
| Title: |
Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses. |
| Volume: |
198 |
| Issue: |
11 |
| Pages: |
4205-4209 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Debierre-Grockiego F |
| Year: |
2007 |
| Journal: |
J Immunol |
| Title: |
Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. |
| Volume: |
179 |
| Issue: |
2 |
| Pages: |
1129-37 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lehnardt S |
| Year: |
2007 |
| Journal: |
J Immunol |
| Title: |
TLR2 and caspase-8 are essential for group B Streptococcus-induced apoptosis in microglia. |
| Volume: |
179 |
| Issue: |
9 |
| Pages: |
6134-43 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
So EY |
| Year: |
2009 |
| Journal: |
Glia |
| Title: |
Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production. |
| Volume: |
57 |
| Issue: |
11 |
| Pages: |
1216-26 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
West XZ |
| Year: |
2010 |
| Journal: |
Nature |
| Title: |
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. |
| Volume: |
467 |
| Issue: |
7318 |
| Pages: |
972-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Eyking A |
| Year: |
2019 |
| Journal: |
J Immunol |
| Title: |
TRIM58 Restrains Intestinal Mucosal Inflammation by Negatively Regulating TLR2 in Myeloid Cells. |
| Volume: |
203 |
| Issue: |
6 |
| Pages: |
1636-1649 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
McKimmie CS |
| Year: |
2009 |
| Journal: |
Blood |
| Title: |
A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. |
| Volume: |
113 |
| Issue: |
18 |
| Pages: |
4224-31 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wu Q |
| Year: |
2011 |
| Journal: |
Am J Physiol Lung Cell Mol Physiol |
| Title: |
In vivo function of airway epithelial TLR2 in host defense against bacterial infection. |
| Volume: |
300 |
| Issue: |
4 |
| Pages: |
L579-86 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cottalorda A |
| Year: |
2006 |
| Journal: |
Eur J Immunol |
| Title: |
TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. |
| Volume: |
36 |
| Issue: |
7 |
| Pages: |
1684-93 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lv J |
| Year: |
2018 |
| Journal: |
Eur J Immunol |
| Title: |
Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation. |
| Volume: |
48 |
| Issue: |
11 |
| Pages: |
1838-1850 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhai Y |
| Year: |
2023 |
| Journal: |
Front Cardiovasc Med |
| Title: |
Aging exacerbates cardiac dysfunction and mortality in sepsis through enhancing TLR2 activity. |
| Volume: |
10 |
|
| Pages: |
1293866 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ha T |
| Year: |
2010 |
| Journal: |
Am J Physiol Heart Circ Physiol |
| Title: |
TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism. |
| Volume: |
298 |
| Issue: |
3 |
| Pages: |
H984-91 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lu C |
| Year: |
2011 |
| Journal: |
J Immunol |
| Title: |
TLR2 ligand induces protection against cerebral ischemia/reperfusion injury via activation of phosphoinositide 3-kinase/Akt signaling. |
| Volume: |
187 |
| Issue: |
3 |
| Pages: |
1458-66 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shin HS |
| Year: |
2011 |
| Journal: |
J Immunol |
| Title: |
Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo. |
| Volume: |
186 |
| Issue: |
2 |
| Pages: |
1119-30 |
|
•
•
•
•
•
|